Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
Chinook Therapeutics has launched with $65 million in series A funding to develop small-molecule drugs for kidney diseases. The firm was incubated in Versant Venture’s Inception Sciences center in Vancouver, British Columbia, and is led by several veterans of big pharma and biotech firms. Chinook says it will use single-cell RNA sequencing, human-derived organoids, and new translational methods to discover drugs.
This article has been sent to the following recipient: